Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
(Source: Trials)
Source: Trials - September 1, 2021 Category: Research Source Type: clinical trials

Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
DiscussionThis trial will determine whether CCP will reduce intubation or death non-intubated adults with COVID-19. The trial will also provide information on the role of and thresholds for SARS-CoV-2 antibody titres and neutralization assays for donor qualification.Trial registrationClinicaltrials.govNCT04348656. Registered on 16 April 2020. (Source: Trials)
Source: Trials - May 4, 2021 Category: Research Source Type: clinical trials

Prophylaxis Vaccine Antibodies Ebola
Condition:   Ebola Virus Disease Interventions:   Drug: ansuvimab;   Biological: Ervebo Sponsor:   ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2021 Category: Research Source Type: clinical trials